Products
Latest press and releases on orthopaedic products, devices, implants and services.
- Written by Jessica James
- Category: Products
Simpleware ScanIP represents software for converting 3D image data (MRI, CT, micro-CT...) into models suitable for CAD, CAE, and 3D Printing applications in Orthopaedics.
- Written by Editor-in-Chief
- Category: Products
The U.S. Food and Drug Administration reports that Medtronic has issued a safety communication regarding the use of non-Medtronic instruments with the company’s NavLock Tracker.
- Written by Editor-in-Chief
- Category: Products
Around 100 drug inspectors have been trained as part of the Gujarat Food and Drug Administration (FDCA)'s collaboration with Abbott India to train and equip FDCA officers on medical devices. As part of strategic partnership for knowledge sharing at the recently concluded Vibrant Gujarat Global Summit (VGGS) - 2017 at Gandhinagar, the initiative has helped drug inspectors in analysing drug samples, devices and auditing manufacturing units. Gujarat government had signed eight such strategic partnerships with overseas and Indian companies to upgrade the knowledge of the Gujarat FDCA officers on relevant areas of concern of the regulatory authorities globally and in India.
- Written by Editor-in-Chief
- Category: Products
NEW DELHI: Over 20 medical devices that are notified as 'drugs' must all carry the maximum retail price on the packs, drug pricing regulator NPPA said today. These devices include heart valves, surgical dressings, condoms, stents, disposable hypodermic syringes and orthopaedic implants. "It has come to knowledge of NPPA that several medical devices are available in the market and also being used in health care facilities where no MRP is printed on the package by manufacturers/importers," National Pharmaceutical Pricing Authority (NPPA) said in a notification. This is a blatant violation of law of the land, it added.
- Written by Editor-in-Chief
- Category: Products
New Delhi: After controlling prices of stents, India’s drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA), has made it mandatory for the manufacturers and importers of “notified” medical devices to carry maximum retail price (MRP) on the packs. These devices include heart valves, catheters, bone cements, surgical dressings, condoms, stents, disposable hypodermic syringes, orthopaedic implants, intra ocular lenses, umbilical tapes, intra uterus devices among others. “It has come to knowledge of the NPPA that several medical devices are available in the market and are also being used in healthcare facilities where no MRP is printed on the package by manufacturers/importers,” the NPPA said in a notification.
- Written by Editor-in-Chief
- Category: Products
OpenPR ist the nicest and most clearly laid out PR platform I have seen to this day. The press releases are displayed very nicely and clearly and without any unnecessary frills. The updates are fast and the finished release looks appealing and is clearly legible. Even with 16 years of experience one discovers new things from time to time. Congratulations! Gabriele Ketterl,Director Marketing & PR, Menads
- Written by Editor-in-Chief
- Category: Products
Orthopedic Trauma Devices Market Orthopedic Trauma Devices Market is expected to grow at a CAGR of ~8% during the forecasted period ,Orthopedic Trauma Devices Market by material, by product-type, by end user | Orthopedic Trauma Devices Market Market Scenario Orthopaedic trauma devices market is expected to grow with CAGR of ~8% during the forecasted period. Orthopedic trauma is a type of severe injury occurred in musculoskeletal system like bones, joints, or ligaments. In some cases, it presents a life-threatening medical emergency while in some it is a need of urgent attention but the patient is not in imminent danger.
- Written by Editor-in-Chief
- Category: Products
Here are five observations: 1. In 2013, the neurosurgery application segment captured the largest image-guided surgery devices market share. 2. The orthopedic surgery application segment is expected to grow at a compound annual growth rate of 7 percent through 2022, the highest of all market segments. 3. The image-guided surgery devices market will grow in North America and Europe, due to adoption of new technologies and access to skilled professionals. 4. The Asia-Pacific region will see the highest growth rate of 6.9 percent through 2022, due to an expanding medical tourism industry and growing government support.
- Written by Editor-in-Chief
- Category: Products
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact This email address is being protected from spambots. You need JavaScript enabled to view it. document.getElementById('cloak958b2a1a6c2d7759587ff14332247774').innerHTML = ''; var prefix = 'ma' + 'il' + 'to'; var path = 'hr' + 'ef' + '='; var addy958b2a1a6c2d7759587ff14332247774 = 'pressreleases' + '@'; addy958b2a1a6c2d7759587ff14332247774 = addy958b2a1a6c2d7759587ff14332247774 + 'franklyinc' + '.' + 'com'; var addy_text958b2a1a6c2d7759587ff14332247774 = 'pressreleases' + '@' + 'franklyinc' + '.' + 'com';document.getElementById('cloak958b2a1a6c2d7759587ff14332247774').innerHTML += ''+addy_text958b2a1a6c2d7759587ff14332247774+''; SOURCE American Orthopaedic Foot & Ankle Society ROSEMONT, Ill. and WEST LEBANON, N.H., Mar. 1, 2017 /PRNewswire-USNewswire/ -- The American Orthopaedic Foot & Ankle Society® (AOFAS) and M2S® proudly announce the launch of the Orthopaedic Foot & Ankle Outcomes Research Network (OFAR)®, a patient-reported outcomes data collection system. Using the M2S PATHWAYS® clinical data platform, OFAR will track clinical and patient-reported outcomes for most orthopaedic foot and ankle conditions.
- Written by Editor-in-Chief
- Category: Products
Total joint arthroplasty is associated with high patient satisfaction and functional improvement. With approximately 400,000 Medicare beneficiaries undergoing the procedure annually, total joint arthroplasty represents the largest total cost of all surgical procedures in the U.S. Centers for Medicare & Medicaid Services (CMS) budget1-3. This has resulted in vigorous efforts by the CMS to control costs without negatively affecting outcomes. Alternative payment methods, such as bundling, allow the CMS to control costs by reimbursing for value rather than volume. The Comprehensive Care for Joint Replacement (CJR) program for a 90-day bundled payment represents CMS’s most recent alternative payment method designed to accomplish this cost-containment goal
Submit Community Content
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!